Treatment of age-related macular degeneration in one eye may increase the risk of glaucoma in another eye. The study found that people receiving seven or more bevacizumab injection in a year can be considered as a high-risk group of developing glaucoma. Age-related macular degeneration (AMD), diabetic edema associated with retinal vein occlusion are the common cause of loss of vision in the elderly patient. The advent of intravitreous anti-vascular endothelial growth factor (VEGF) injection has significantly improved the visual outcome of the patient.
However, repeated intravitreous anti-VEGF injections can cause a sustained increase in intraocular pressure (IOP). Several studies revealed that this sustained IOP rise is positively associated with a number of injections received and this may also increase the risk of glaucoma outcome. Age-related macular degeneration (AMD) AMD is a…
